198 related articles for article (PubMed ID: 38566250)
1. Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach.
Rao S; Sadybekov A; DeWitt DC; Lipka J; Katritch V; Herring BE
Mol Autism; 2024 Apr; 15(1):12. PubMed ID: 38566250
[TBL] [Abstract][Full Text] [Related]
2. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
[TBL] [Abstract][Full Text] [Related]
3. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio.
Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE
Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363
[TBL] [Abstract][Full Text] [Related]
4. An Intellectual Disability-Related Missense Mutation in Rac1 Prevents LTP Induction.
Tian C; Kay Y; Sadybekov A; Rao S; Katritch V; Herring BE
Front Mol Neurosci; 2018; 11():223. PubMed ID: 30042656
[TBL] [Abstract][Full Text] [Related]
5. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.
Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D
Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental disease-associated de novo mutations and rare sequence variants affect TRIO GDP/GTP exchange factor activity.
Katrancha SM; Wu Y; Zhu M; Eipper BA; Koleske AJ; Mains RE
Hum Mol Genet; 2017 Dec; 26(23):4728-4740. PubMed ID: 28973398
[TBL] [Abstract][Full Text] [Related]
7. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
8. Opposing Effects on Na
Ben-Shalom R; Keeshen CM; Berrios KN; An JY; Sanders SJ; Bender KJ
Biol Psychiatry; 2017 Aug; 82(3):224-232. PubMed ID: 28256214
[TBL] [Abstract][Full Text] [Related]
9. TRIO loss of function is associated with mild intellectual disability and affects dendritic branching and synapse function.
Ba W; Yan Y; Reijnders MR; Schuurs-Hoeijmakers JH; Feenstra I; Bongers EM; Bosch DG; De Leeuw N; Pfundt R; Gilissen C; De Vries PF; Veltman JA; Hoischen A; Mefford HC; Eichler EE; Vissers LE; Nadif Kasri N; De Vries BB
Hum Mol Genet; 2016 Mar; 25(5):892-902. PubMed ID: 26721934
[TBL] [Abstract][Full Text] [Related]
10. A case of autism spectrum disorder arising from a de novo missense mutation in POGZ.
Fukai R; Hiraki Y; Yofune H; Tsurusaki Y; Nakashima M; Saitsu H; Tanaka F; Miyake N; Matsumoto N
J Hum Genet; 2015 May; 60(5):277-9. PubMed ID: 25694107
[TBL] [Abstract][Full Text] [Related]
11. Novel missense mutations in PTCHD1 alter its plasma membrane subcellular localization and cause intellectual disability and autism spectrum disorder.
Halewa J; Marouillat S; Dixneuf M; Thépault RA; Ung DC; Chatron N; Gérard B; Ghoumid J; Lesca G; Till M; Smol T; Couque N; Ruaud L; Chune V; Grotto S; Verloes A; Vuillaume ML; Toutain A; Raynaud M; Laumonnier F
Hum Mutat; 2021 Jul; 42(7):848-861. PubMed ID: 33856728
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction of Trio GEF1 involves in excitatory/inhibitory imbalance and autism-like behaviors through regulation of interneuron migration.
Sun X; Wang L; Wei C; Sun M; Li Q; Meng H; Yue W; Zhang D; Li J
Mol Psychiatry; 2021 Dec; 26(12):7621-7640. PubMed ID: 33963279
[TBL] [Abstract][Full Text] [Related]
13. Disrupted-in-Schizophrenia 1-mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signaling.
Chen SY; Huang PH; Cheng HJ
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5861-6. PubMed ID: 21422296
[TBL] [Abstract][Full Text] [Related]
14. Trio's Rho-specific GEF domain is the missing Galpha q effector in C. elegans.
Williams SL; Lutz S; Charlie NK; Vettel C; Ailion M; Coco C; Tesmer JJ; Jorgensen EM; Wieland T; Miller KG
Genes Dev; 2007 Nov; 21(21):2731-46. PubMed ID: 17942708
[TBL] [Abstract][Full Text] [Related]
15. Kirrel3-Mediated Synapse Formation Is Attenuated by Disease-Associated Missense Variants.
Taylor MR; Martin EA; Sinnen B; Trilokekar R; Ranza E; Antonarakis SE; Williams ME
J Neurosci; 2020 Jul; 40(28):5376-5388. PubMed ID: 32503885
[TBL] [Abstract][Full Text] [Related]
16. De novo missense variants disrupting protein-protein interactions affect risk for autism through gene co-expression and protein networks in neuronal cell types.
Chen S; Wang J; Cicek E; Roeder K; Yu H; Devlin B
Mol Autism; 2020 Oct; 11(1):76. PubMed ID: 33032641
[TBL] [Abstract][Full Text] [Related]
17. Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability.
Torrico B; Fernàndez-Castillo N; Hervás A; Milà M; Salgado M; Rueda I; Buitelaar JK; Rommelse N; Oerlemans AM; Bralten J; Freitag CM; Reif A; Battaglia A; Mazzone L; Maestrini E; Cormand B; Toma C
Eur J Hum Genet; 2015 Dec; 23(12):1694-701. PubMed ID: 25782667
[TBL] [Abstract][Full Text] [Related]
18. Genetic and clinical evidence of mitochondrial dysfunction in autism spectrum disorder and intellectual disability.
Valiente-Pallejà A; Torrell H; Muntané G; Cortés MJ; Martínez-Leal R; Abasolo N; Alonso Y; Vilella E; Martorell L
Hum Mol Genet; 2018 Mar; 27(5):891-900. PubMed ID: 29340697
[TBL] [Abstract][Full Text] [Related]
19. Perturbed proteostasis in autism spectrum disorders.
Louros SR; Osterweil EK
J Neurochem; 2016 Dec; 139(6):1081-1092. PubMed ID: 27365114
[TBL] [Abstract][Full Text] [Related]
20. Biallelic
Young N; Asif M; Jackson M; Fernández-Mayoralas DM; de la Peña MJ; Calleja-Pérez B; Álvarez S; Hunter-Featherstone E; Noegel AA; Höhne W; Nürnberg P; Obara B; Hussain MS; Karakesisoglou I; Fernández-Jaén A
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
